Physician profile
Jason Litt
NPI 1962778142
$20,984.79
in general payments reported to CMS, 2019-2025
36 companies · $2,094 in 2025
The $2,094 reported for 2025 was more than what 83% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,800 · 2020: $3,256 · 2021: $3,370 · 2022: $3,064 · 2023: $3,002 · 2024: $2,398 · 2025: $2,094.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,825 · Travel and Lodging: $620 · Education: $49.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,825.19 |
| Travel and Lodging | $619.95 |
| Education | $49.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,461.01 | 2019-2025 | Wavewriter Alpha Prime 16, Infinion 16, Infinion 16 |
| Medtronic, INC. | $4,184.69 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Nevro Corp. | $3,460.44 | 2019-2024 | Senza |
| Abbott Laboratories | $3,457.10 | 2019-2021 | |
| Medtronic USA, INC. | $2,061.39 | 2019-2020 | |
| Curonix LLC | $462.96 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Painteq LLC | $389.33 | 2024 | Painteq |
| Arteriocyte Medical Systems, INC. | $324.71 | 2019 | |
| Collegium Pharmaceutical, INC. | $309.22 | 2022-2025 | Xtampza, Belbuca |
| Vertos Medical, INC. | $261.40 | 2022-2024 | Mild Device Kit |
| Si-Bone, INC. | $193.31 | 2020-2025 | |
| Electronic Waveform Lab, INC. | $188.97 | 2023-2025 | |
| Cumberland Pharmaceuticals, INC. | $167.98 | 2025 | Kristalose |
| Indivior INC. | $149.85 | 2019-2022 | |
| Averitas Pharma INC. | $143.10 | 2023-2025 | Qutenza |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $132.87 | 2025 | Senza |
| Abbvie INC. | $112.17 | 2022-2025 | |
| Mallinckrodt Hospital Products INC. | $62.62 | 2022-2023 | Acthar |
| Biotronik Nro, INC. | $47.53 | 2023-2025 | Biotronik, Prospera |
| Pacira Therapeutics, INC. | $47.11 | 2019 | |
| Pfizer INC. | $45.88 | 2019-2021 | |
| Melinta Therapeutics, LLC | $42.40 | 2021 | |
| Alkermes, INC. | $39.38 | 2019-2021 | |
| Saluda Medical Americas, INC. | $35.97 | 2025 | Evoke |
| Fidia Pharma USA INC. | $29.84 | 2019-2024 | Hyalgan, Hymovis, Triluron |
| Stryker Corporation | $22.67 | 2019 | |
| Bioventus LLC | $19.72 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $18.24 | 2025 | |
| Scilex Pharmaceuticals INC. | $17.69 | 2023 | Ztlido |
| Djo, LLC | $17.13 | 2023 | Donjoy, Aircast |
| Smith+Nephew, INC. | $15.80 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $14.34 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.10 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.08 | 2023 | Seglentis |
| Lilly USA, LLC | $11.66 | 2019 | |
| Ermi LLC | $10.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Litt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.